LEADER 03814nam  22005655  450 
001 9910254517603321
005 20200701143505.0
010   $a3-319-24741-7
024 7 $a10.1007/978-3-319-24741-0
035   $a(CKB)3710000000532387
035   $a(EBL)4187989
035   $a(SSID)ssj0001597385
035   $a(PQKBManifestationID)16297323
035   $a(PQKBTitleCode)TC0001597385
035   $a(PQKBWorkID)14886721
035   $a(PQKB)10062684
035   $a(DE-He213)978-3-319-24741-0
035   $a(MiAaPQ)EBC4187989
035   $a(PPN)190881410
035   $a(EXLCZ)993710000000532387
100   $a20151207d2016      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aPharmacovigilance in Psychiatry$b[electronic resource] /$fedited by Edoardo Spina, Gianluca Trifirņ
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Adis,$d2016.
215   $a1 online resource (320 p.)
300   $aDescription based upon print version of record.
311   $a3-319-24739-5 
320   $aIncludes bibliographical references at the end of each chapters.
327   $a1. Introduction: History of pharmacovigilance in psychiatry -- 2. Adverse drug reactions: definition and pathogenesis -- 3. Methodologies for pharmacovigilance monitoring of psychotropic drugs -- 4. The role of prescription event monitoring in pharmacovigilance of psychotropic drugs -- 5. The role of healthcare databases in pharmacovigilance of psychotropic drugs -- 6. Monitoring of plasma concentrations of psychotropic drugs in pharmacovigilance -- 7. The role of pharmacogenetics in pharmacovigilance of psychotropic drugs -- 8. Safety and tolerability of antidepressants -- 9. Safety and tolerability of antipsychotics -- 10. Safety and tolerability of anxiolytics/sedative hypnotics -- 11. Safety and tolerability of mood stabilizers -- 12. Safety and tolerability of medications for ADHD -- 13. Safety of psychotropic drugs in children and adolescents -- 14. Safety of psychotropic drugs in the elderly(Safety of psychotropic drugs in the elderly -- 15. Safety of psychotropic drugs in pregnancy and breastfeeding.
330   $aThe first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance. Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience. Pharmacovigilance in psychiatry provides a thorough introduction to this field but goes on to explore advanced themes such as methodologies and resources used for pharmacovigilance in psychiatry, challenges as well as most recent developments to this field, making it suitable for under-graduates, graduate and post-doctoral students and persons working pharmacovigilance who seek to broaden their knowledge on this subject.
606   $aPsychopharmacology
606   $aPharmacy
606   $aPsychopharmacology$3https://scigraph.springernature.com/ontologies/product-market-codes/H53010
606   $aDrug Safety and Pharmacovigilance$3https://scigraph.springernature.com/ontologies/product-market-codes/H69010
615  0$aPsychopharmacology.
615  0$aPharmacy.
615 14$aPsychopharmacology.
615 24$aDrug Safety and Pharmacovigilance.
676   $a610
702   $aSpina$b Edoardo$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aTrifirņ$b Gianluca$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254517603321
996   $aPharmacovigilance in Psychiatry$92513385
997   $aUNINA